An Introduction to the Innovation Fund
EIS investments into businesses that impact key global issues Founded 2014 | St Andrews, Scotland
Disease Diagnosis, Food & Energy Security Improvement and Disease Diagnosis, Food & Water EneIrsgsyu Seesc, uCrliitmy ate Prevention & TrPeraetvmeennttion & Water Security Issues, Climate Change Sustainability of Treatment Security C&h aPnoglluet i&o nPollution Industrial Processes S/EIS Investing with Eos
Eos
There are 4 pillars to Eos investments, our Angel Syndicate, International Institutional Investors Venture Partners, Public Co-Investors including Scottish Enterprise, and Other the EIS Innovation Fund. Syndicates
The Eos EIS Innovation Fund also accesses some SEIS investments for those benefiting from entrepreneurial tax relief. The Fund is suitable for investors Public and financial advisors who are looking to diversify their investment portfolio Independent Co-investment Founders & Private Management and specifically interested in impact investing in business addressing global Investors issues. Investments from £25k, split between a minimum of five investments. Growth in funding for the Eos portfolio The Innovation Fund is an evergreen fund in the range of £1-5 million with a typical investment cycle of 5-8 years. Investments are only into early-stage businesses with global market potential, protectable IP, and credible 13 5 : 1 12 £27m management teams so that as these businesses build to a successful exit, Investee Businesses Historical Investment Scottish Universitires / Total Investment the returns are commensurate. Ratio Research Centres into Portfolio
Impact investors 'Hands-on' investors Therefore those who work with us are Eos works closely with its portfolio companies to give them direction & support. Every one of our motivated both by the financial growth of portfolio companies has performed according to plan or better and none have failed. Many have grown our portfolio, and the positive impact they considerably through follow-on investment rounds and sales, which is a track record we are proud of. are having on global challenges. Over the Our first exits are due in 2021. The Innovation Fund gives access to this same qualified deal flow, as well first 6 years, Eos has invested through its as the significant tax relief from early-stage investing. Our Investment Committee who lead these deals syndicate only, with an investment ratio of are introduced on the next page and come from a very diverse background, from government advisors 5 : 1 between Eos and co-investment to record breakers, business leaders from large corporates and SME, from scientists to entrepreneurs. partners, as well as Scottish Enterprise. We back people with innovations that are IP protected, that can have a positive impact on the world.
The Eos Innovation Fund Information Memorandum is available upon request for full investment details [email protected] Eos Advisory LLP is an Appointed Representative of Javelin Ventures Limited (FCA Ref:207918), which is authorised and regulated by the Financial Conduct Authority Investment Committee
Valerie Jolliffe Kevin Grainger Andrew McNeill Phd Mark Beaumont BEM Chris Brinsmead CBE Rick Clark Ana Stewart Investment Committee Eos Advisory Chairman Eos Advisory Managing Eos Advisory Partner Eos Advisory Partner Eos Advisory Partner Eos Advisory Partner & Fund Manager Partner Valerie founded Javelin Kevin Grainger is a serial Andrew McNeill has over 15 Mark Beaumont spent the Chris Brinsmead is a council Rick is the CFO of a private Ana founded her digital Ventures Limited in 2001 entrepreneur with over 35 years’ experience in leading first 15 years of his career member at Imperial College equity-funded business in consultancy business after currently also manages years track record in the IT early stage venture capital building teams around London, a former adviser to the energy sector and is a graduating from University EIS funds for Newable and investment sectors. backed medical device and sporting success and is the UK Government on life NXD of two other and grew it into a leading (London) and Halo Having worked in both biotech companies. Andrew best known as an athlete sciences, has previously held companies. He is also on global innovator consumer Business Angels (Belfast.) corporate and SME/start- holds a PhD in Molecular and BBC broadcaster. He senior executive roles at ICI, the board of a charity engagement software. As Valerie also acts as head up environments, Kevin Physics from Leeds still holds the 18,000-mile Zeneca and AstraZeneca, which owns and operates 2 CEO, she led the AIM listing of finance for one of the has a wealth of business University. He was part of circumnavigation cycling and over the last decade has nationally-significant of the company on the Iceni spin-outs. Valerie experience and a university the founding team at record in a time of 78 days been a non-executive board museums and is a member London Stock Exchange has a degree in education in physics that Ambicare Health, a medical along. Mark’s degree member and chair on a of the ICAS Ethics Board. and was voted Emerging engineering from lead to a passion for seeing device company in the education was in number of private and His prior experience in the Entrepreneur of the Year by Cambridge University, a innovative technologies oncology space and took Economics & Politics, and public limited company energy sector was with a the Scottish masters in charity finance and science being several technologies from lab for over thirteen years he boards. And from 2010 until technology-led oilfield Entrepreneurial Exchange. and accounting from successfully through to market. has also worked with LDC, 2017 he was an independent services company which he Ana sold then sold the Cass Business School, and commercialised. Kevin Subsequent to that he was the UK’s leading mid- Advisor to the Prime helped build rapidly prior to company in a US trade sale. is a Chartered Secretary. founded Eos in 2014. CEO of biotechnology market private equity firm, Minister and other senior its successful sale. Before Ana sits on the Board of the company Fixed Phage before in their deal origination government ministers on that he was a partner with Scottish FA and also sits on joining Eos in 2017. team. Life Sciences 2010. KPMG for 15 years. the main council of ICAS.
Examples of our Investment Directors
Jock Gardiner Kenneth Fraser Richard Cooper Extensive experience in corporate finance (KPMG qualified Director & Chairman experience with a number of Scottish Chartered Engineer with over 40 years of operational and CA) and private equity (Aberdeen Asset Management PLC SMEs in roles from relationships with various Private Equity board-level experience of blue-chip and SME companies. and founder partner of Maven Capital Partners) with a companies including 3i, ECI, Charterhouse & HBOS. Ken 5 : 1 Richard has had senior roles in manufacturing operations, strong track record particularly in the energy services served on the Scottish Council of the Institute of Directors, andHistorical Invqeustamliteyn, itnternaStciootntiaslh b Uunsiinversssi tdireevse /lopment, and sales Research Centres sector. Joint Founder of Alba Equity angel investor group from 2005 to 2010 was Scotland’s employers representative on Ratioalongside raising funds for company growth. and various Non-Executive Director and Consultancy roles. the European Economic and Social Committee in Brussels. Investing in the Fund - Step by Step
Investing Investment Exit Application Over a 18 - 24 month period Assuming a successful 3 the Fund aims to invest in a Claim Tax Relief 1 Once you have taken appropriate 7 exit, capital is returned to diversified portfolio of at advice and decided to invest you Submit your S/EIS Form to Investors as realisations least 5 knowledge intensive will find the Investor Agreement, 5 HMRC to claim your initial 5 are made net of fees. companies. KID and application form on our tax relief, if eligible. website: eos-advisory.com. The fund is open to investors all year round.
S/EIS and Share 4 Documentation You will receive your Contract Investment Reported Deposit Subscriptions Note and S/EIS Form following each investment. 6 We share a Fund valuation report Once your application is approved, you will 2 Your shares are held by twice a year with each investor. The deposit your funds with a separate custodian Mainspring Nominees Limited report includes a valuation and organisation, Mainspring Nominees Limited, as Nominees performance update for each of the who is a leading provider of S/EIS custodian portfolio companies. & administration services.
Risks
Investing in early-stage businesses carries a high degree of risk and Investors may lose all or part of their investment. Investors need to be comfortable with the level of risk to which they are exposed. Where appropriate investors should seek specific advice on tax and investment matters from suitably qualified advisors.